about
Resolvin D1, resolvin D2 and maresin 1 activate the GSK3β anti-inflammatory axis in TLR4-engaged human monocytesFine-tuning of NFκB by glycogen synthase kinase 3β directs the fate of glomerular podocytes upon injury.Noncanonical activation of β-catenin by Porphyromonas gingivalis.Model-Based Characterization of Inflammatory Gene Expression Patterns of Activated Macrophages.2-Amino-4-(3,4-(methylenedioxy)benzylamino)-6-(3-methoxyphenyl)pyrimidine is an anti-inflammatory TLR-2, -4 and -5 response mediator in human monocytes.Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancerThe β isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy.Glycogen synthase kinase 3β in Toll-like receptor signaling.Syk negatively regulates TLR4-mediated IFNβ and IL-10 production and promotes inflammatory responses in dendritic cells.Immunosenescence in monocytes, macrophages, and dendritic cells: lessons learned from the lung and heart.Pilot study of lithium to restore intestinal barrier function in severe graft-versus-host diseaseSCFFBXO17 E3 ligase modulates inflammation by regulating proteasomal degradation of glycogen synthase kinase-3β in lung epithelia.Inhibition of glycogen synthase kinase 3 beta (GSK3β) suppresses the progression of esophageal squamous cell carcinoma by modifying STAT3 activity.Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015).Stressed and Inflamed, Can GSK3 Be Blamed?Anti-malarial Activities of Two Soil Actinomycete Isolates from Sabah via Inhibition of Glycogen Synthase Kinase 3βThe GSK3/Shaggy-Like Kinase ASKα Contributes to Pattern-Triggered Immunity.A partnership with the proteasome; the destructive nature of GSK3.Inhibition of GSK3α/β impairs the progression of HNSCC.
P2860
Q29248096-7CE32325-A66B-4674-8AAD-FB0A4A80C8B7Q35667727-723709F0-D1AD-4AB2-A968-7A5D0F5EEF6FQ35833765-70461F70-A031-4725-9A72-F146CD2838F5Q36087549-FD713655-97F4-4B49-AFB7-7D9C3811F008Q36437070-E5E3B488-C669-4932-BED8-0B92FCC2EC92Q36475989-33D3993C-1ABA-4B45-ACB7-B4AA716B234AQ36803722-AC4266FB-854F-4F60-9D06-9F40D31AB149Q37351177-3992D6B1-8B51-4091-B61A-4D08DB621C03Q37660568-CBD8885C-9A2D-4466-9AFC-DB8055296A9BQ38253911-82980499-7821-49F4-A6F7-7BE907FB5BECQ38619812-CE0B6109-67E4-4AD2-81DF-FE067CC68D5BQ38712145-986955BE-4F42-4391-A5CA-6A005B56EFD7Q38748837-7E0D0BAC-4CAA-4F43-A8FA-F8446DFFF8B8Q39003757-17D7F5C7-2F72-433F-A26B-1061436DE981Q39017112-F9D8751E-F6E5-4D5A-A339-858C38B831EBQ39335534-AE9831A8-BBD5-4E42-AA82-0E0A18B60D2CQ39747610-CE44B4D6-2D11-4020-89D4-F0E111601E59Q47441648-71FD26DE-A840-4B3E-8B14-B3E47F92207AQ55456154-009C6C2F-5DF3-404D-BCC5-6956D1D3D549
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
GSK3β and the control of infectious bacterial diseases
@ast
GSK3β and the control of infectious bacterial diseases
@en
GSK3β and the control of infectious bacterial diseases
@nl
type
label
GSK3β and the control of infectious bacterial diseases
@ast
GSK3β and the control of infectious bacterial diseases
@en
GSK3β and the control of infectious bacterial diseases
@nl
prefLabel
GSK3β and the control of infectious bacterial diseases
@ast
GSK3β and the control of infectious bacterial diseases
@en
GSK3β and the control of infectious bacterial diseases
@nl
P2093
P2860
P3181
P1476
GSK3β and the control of infectious bacterial diseases
@en
P2093
Akhilesh Kumar
David A. Scott
Huizhi Wang
Richard J. Lamont
P2860
P304
P3181
P356
10.1016/J.TIM.2014.01.009
P407
P577
2014-04-01T00:00:00Z